LigoLab Applauded by Frost & Sullivan for Transforming Diagnostic Laboratories with its All-in-One Integrated LIS & RCM Platform
LigoLab's Laboratory Operating Platform drives profit and revenue, improves efficiency, and delivers holistic testing services across multiple segments in diagnostic laboratories SAN ANTONIO, Jan. 18, 2022 /PRNewswire/ -- Frost & Sullivan recently analyzed the North American Laboratory Information Systems Industry and recognizes LigoLab as the 2022 Competitive Strategy Leadership Award winner for improving the efficiency of diagnostic laboratories and transforming them into thriving businesses....
Akeso’s AK117 (CD47 monoclonal antibody) in Combination with AK112 (PD-1/VEGF bi-specific antibody) to Initiate a Phase Ib/II Clinical Trial with or without Chemotherapy for the Treatment of Advanced Malignant...
HONG KONG, Jan. 18, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) announces that Ligufalimab (CD47 monoclonal antibody, research and development code: AK117), the novel immuno-oncology drug independently developed by the Company, combined with Ivonescimab (PD-1/VEGF bi-specific antibody, research and development code: AK112) has obtained approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration of the...
Servier Group Reports Financial Year 2020/2021 Annual Results, R&D Strategy and Pipeline
- Consolidated revenue of €4.725 billion, up +4.3% at constant rates (+0.8% at current rates) - Revenue for brand-name medicines of €3.306 billion +4.8% at constant rates (+0.6% at current rates) and €1.419 billion for the generics +2.9% at constant rates (+1.1% at current rates) - An accelerated oncology...
Ascletis Announces Signing of Ritonavir Tablet Purchase Agreement with Phokam Pharmaceutical Import-Export Co., Ltd of Laos
HANGZHOU and SHAOXING, China, Jan. 18, 2022 /PRNewswire/ -- Ascletis Pharma Inc. ("Ascletis") (HKEX: 1672) today announces signing of the ritonavir tablet purchase agreement between Phokam Pharmaceutical Import-Export Co., Ltd (as buyer) of Laos and Ascletis Pharmaceuticals Co., Ltd. (as seller), a wholly-owned subsidiary of Ascletis Pharma Inc. Ritonavir oral tablet is a pharmacokinetic booster of multiple...
MindRank Begins IND-enabling Studies of its first AI-designed Drug, 8 Months After Program Initiation
HANGZHOU, China, Jan. 18, 2022 /PRNewswire/ -- MindRank AI, an artificial intelligence (AI) driven biotech company, today announced that the company has nominated a preclinical candidate (PCC) for an important class B GPCR drug target, 8 Months After Program Initiation. Historically, the development of small-molecule agonists of class B GPCRs has proven particularly challenging. Among the fewer than 100...
Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials
- Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq - Spin-off to unlock value in the space of medical dermatology by using Novaliq's transformative technology outside eye care - 3E Bioventures Capital and Beijing Whale Technology Corporation Ltd join as new investors - Proceeds will be used for three Phase 1/2a clinical development programs...
e-BEAUTY LAUNCHES DNA TEST KITS FOR ASIANS
Singapore-Based Company Develops Direct-to-Consumer DNA Test For Asians Asian Screening Array Technology (ASA) Provides Most Accurate DNA Results for Asians Online-to-Offline (O2O) Platform Allows Consumers to Submit Saliva Samples From Home SINGAPORE, Jan. 18, 2022 /PRNewswire/ -- Singapore-based beauty platform, e-beauty, has developed a DNA home-test kit to help consumers discover the full spectrum...
Genetech Biotechnology Launches Four Exclusive Promo Bundles For Citrea In Celebration Of Chinese New Year
Half the price deals for Prosperity Bundle, Pampering Duo, CNY (Clean New Year) Pair and Abundance Combo, for a limited time only SINGAPORE, Jan. 18, 2022 /PRNewswire/ -- Genetech Biotechnology, the exclusive distributor of Citrea, launches four exclusive promo bundles to celebrate Chinese New Year. The four bundle sets, The Prosperity Bundle, The Pampering Duo, CNY...
InnoCare and Keymed Jointly Announce Dosing of First Patient in Clinical Trial of CD20xCD3 Bispecific Antibody CM355
BEIJING, Jan. 18, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the first patient in China has been dosed in clinical trial of CM355, a CD20xCD3 bispecific antibody developed by a joint venture between the two companies, for the treatment of CD20+ B-cell malignancies. CM355 binds to CD20 on the...
WuXi Biologics Completes GMP Inspection by South Korea’s Ministry of Food and Drug Safety for Drug Substance Facility
WuXi Biologics completes the first GMP inspection in 2022, demonstrating the company's premier quality system is in full compliance with global regulatory requirements. WUXI, China, Jan. 18, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by South Korea's...
